Whole genome and transcriptome analysis of metastatic adrenocortical carcinoma

Dr Jean-Michel Lavoie speaks to ecancer at the 2019 ASCO Genitourinary Cancers Symposium about the study looking at the whole genome and transcriptome analysis of metastatic adrenocortical carcinoma.

He reveals that among the findings of the analysis are a number of known mutations including mutations in pathways that affect the cell cycle and DNA damage repair that could suggest alternative treatments.

Dr Lavoie acknowledges that so far the information collected must be considered within the wider literature but that more and more information is being collected and that this could lead to clinical trials.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php